Advertisement

Enhancing the Value of PCSK9 Monoclonal Antibodies by Identifying Patients Most Likely to Benefit

Last Updated: Thursday, 16-May-2019 19:15:00 EDT

Enhancing the Value of PCSK9 Monoclonal Antibodies by Identifying Patients Most Likely to Benefit

Jennifer G Robinson, MD, MPH, Manju Bengularu Jayanna, MBBS, Alan S. Brown, MD, FACC, FNLA, Karen Aspry, MD, MS, FACC, FNLA, FAHA, Carl Orringer, MD, FNLA, Edward A. Gill, MD, FNLA, FASE, FACP, FACC, FAHA, Anne Goldberg, MD, FACP, FNLA, Laney K. Jones PharmD, MPH, Kevin Maki, PhD, Dave L. Dixon, PharmD, Joseph Saseen PharmD, FNLA, Daniel Soffer, MD, FNLA, FACP

National Lipid Association Statement

View Manuscript

 

Resources

Media

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service